Welcome Calquence

My new weapon of choice in the ongoing battle against chronic lymphocytic leukemia. My last med was quite effective for about 3 years but then started yielding some undesirable side effects so we opted to move on down the line in treatment options. In my 15 + plus years living with this, I’ve now been through the following oral and IV (54 infusions) medications: fludarabine (Fludara), rituximab (Rituxan), Decadron, Prednisone,

bendamustine (Bendeka),

ibrutinib (Imbruvica), and now acalabrutinib (Calquence). And while that may sound like a lot, I’m extremely grateful that I do indeed have options available to me. You’re up #calquence and #AstraZeneca! So far, so good on this and hopefully this will be a long term solution. But if not, I rest assuredly knowing that other options do and will exist thanks to the incredible work being done in the #bloodcancer community. #cancer #leukemia #cll #survivor #livingabove #patient #patientadvocate #patientadvocacy

My new weapon of choice in the ongoing battle against chronic lymphocytic leukemia. My last med was quite effective for about 3 years but then started yielding some undesirable side effects so we opted to move on down the line in treatment options. In my 15 + plus years living with this, I’ve now been through the following oral and IV (54 infusions) medications: fludarabine (Fludara), rituximab (Rituxan), Decadron, Prednisone, bendamustine (Bendeka), ibrutinib (Imbruvica), and now acalabrutinib (Calquence).

And while that may sound like a lot, I’m extremely grateful that I do indeed have options available to me. You’re up #calquence and #AstraZeneca! So far, so good on this and hopefully this will be a long term solution. But if not, I rest assuredly knowing that other options do and will exist thanks to the incredible work being done in the #bloodcancer community. #cancer #leukemia #cll #survivor #livingabove #patient #patientadvocate #patientadvocacy